Pharma Business Daily
Claim your FREE trial subscription!


Health Markets:

The Worldwide Influenza Market

BCC Research
Market Study  May 2006

Paper - USD 4250.00  
Single-user PDF - USD 4850.00  
Global Site License - USD 8500.00  


Table of Contents

REPORT HIGHLIGHTS
  • By 2010, the worldwide influenza market is likely to reach $7.1 billion, with average annual growth estimated at 19.8%.
  • The worldwide influenza market is estimated at $2.9 billion in 2005, up from $1.5 billion the previous year.
  • The market is estimated to reach $7.1 billion in 2010, an increase of more than $4.2 billion over the forecast period.
  • The worldwide therapeutics/vaccines market is likely to reach $6.9 billion in 2010, with average annual growth estimated at 20.8%.

 



INTRODUCTION

Annually, more than 3.5 million people die of influenza, and with the threat of a pandemic government agencies and disease prevention organizations are devoted to gain control of the situation. Many companies have been asked to assist with the problem and others are furthering their position with backing from government agencies. The next year will continue to display support and funding for many research and development programs, product development and pandemic prevention and/or control.

This new report from BCC Research is designed to be a helpful business tool that will provide thorough evaluation of the market for influenza vaccines, therapeutics, and diagnostics. The geographic scope of this study is worldwide, with emphasis on U.S. data. The report identifies markets in general segments: Vaccines/ Therapeutics and Diagnostics. Each market segment discussion provides detailed information based on product categories, use of products, forecasts, and competitive analysis. Additionally, the study covers some of most significant issues and trends and market factors.

SCOPE OF STUDY

This report:
  • Provides a thorough evaluation of the market for influenza vaccines, therapeutics, and diagnostics.
  • Offers a global analysis, with emphasis on U.S. data, and a five-year forecast period through 2010.
  • Identifies markets in general segments: Vaccines/Therapeutics and Diagnostics. Each market segment discussion provides detailed information based on product categories, use of products, forecasts, and competitive analysis.
  • Covers some of the most significant issues, trends and market factors.
  • Profiles the top companies and major players in the market.




For full details, please email jenniferc@cmsinfo.com

Order Form




CMS, P&A House, Alma Road, Chesham, Bucks. HP5 3HB, UK
Tel:     +44 (0)1494 771734
Fax:   +44 (0)1494 778994
e-mail: Jennifer Cowlard
copyright © 2008 all rights reserved

For more information about us, visit CMSinfo.

footer bar